Jazz files US patent complaint against Avadel over Xyrem
MLex Summary: Jazz Pharmaceuticals filed a US complaint accusing Avadel of infringing a patent related to the drug Xyrem. See attached file. ...To view the full article, register now.
Already a subscriber? Click here to view full article